Zai Lab Limited (HKG:9688)
Hong Kong · Delayed Price · Currency is HKD 21.48
+0.52 (2.48%)
Nov 10, 2026, 4:08 PM HKT
Zai Lab Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 441.73 | 460.16 | 398.99 | 266.72 | 215.04 | 144.31 | |
Revenue Growth | 0.02% | 15.33% | 49.59% | 24.03% | 49.01% | 194.77% |
Cost of Revenue | 438.93 | 411.99 | 382.36 | 361.68 | 360.43 | 625.55 |
Gross Profit | 2.79 | 48.17 | 16.62 | -94.97 | -145.39 | -481.23 |
Selling, General & Admin | 281.05 | 277.61 | 298.74 | 281.61 | 258.97 | 218.83 |
Operating Expenses | 281.05 | 277.61 | 298.74 | 281.61 | 258.97 | 218.83 |
Operating Income | -278.26 | -229.43 | -282.12 | -376.57 | -404.36 | -700.06 |
Interest Expense | -6.16 | -5.21 | -2.25 | - | - | - |
Interest & Investment Income | 25.31 | 33.05 | 37.11 | 39.8 | 14.58 | 2.19 |
Earnings From Equity Investments | - | - | - | - | -0.22 | -1.06 |
Currency Exchange Gain (Loss) | 50.11 | 19.59 | -15.14 | -14.85 | -56.4 | 4.66 |
Other Non Operating Income (Expenses) | 8.14 | 5.45 | 11.41 | 4.22 | 12.07 | 4.42 |
EBT Excluding Unusual Items | -200.86 | -176.55 | -251 | -347.41 | -434.33 | -689.85 |
Gain (Loss) on Sale of Investments | -1.91 | -1.91 | -6.11 | 2.79 | -8.95 | -14.62 |
Gain (Loss) on Sale of Assets | - | - | - | 10 | - | - |
Pretax Income | -202.77 | -178.46 | -257.1 | -334.62 | -443.29 | -704.47 |
Income Tax Expense | -4.38 | -2.93 | - | - | - | - |
Net Income | -198.39 | -175.54 | -257.1 | -334.62 | -443.29 | -704.47 |
Net Income to Common | -198.39 | -175.54 | -257.1 | -334.62 | -443.29 | -704.47 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 1,114 | 1,095 | 989 | 966 | 958 | 930 |
Shares Outstanding (Diluted) | 1,114 | 1,095 | 989 | 966 | 958 | 930 |
Shares Change | 3.60% | 10.70% | 2.39% | 0.87% | 3.03% | 19.73% |
EPS (Basic) | -0.18 | -0.16 | -0.26 | -0.35 | -0.46 | -0.76 |
EPS (Diluted) | -0.18 | -0.16 | -0.26 | -0.35 | -0.46 | -0.76 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -163.34 | -158.89 | -220.53 | -205.39 | -392.23 | -567.53 |
Free Cash Flow Per Share | -0.15 | -0.14 | -0.22 | -0.21 | -0.41 | -0.61 |
Gross Margin | 0.63% | 10.47% | 4.17% | -35.60% | -67.61% | - |
Operating Margin | -62.99% | -49.86% | -70.71% | -141.19% | -188.04% | -485.10% |
Profit Margin | -44.91% | -38.15% | -64.44% | -125.46% | -206.14% | -488.16% |
Free Cash Flow Margin | -36.98% | -34.53% | -55.27% | -77.01% | -182.40% | -393.26% |
EBITDA | -261.81 | -214.42 | -270.26 | -367.54 | -396.13 | -693.58 |
EBITDA Margin | -59.27% | -46.60% | -67.74% | -137.80% | -184.21% | - |
D&A For EBITDA | 16.44 | 15.01 | 11.86 | 9.03 | 8.23 | 6.49 |
EBIT | -278.26 | -229.43 | -282.12 | -376.57 | -404.36 | -700.06 |
EBIT Margin | -62.99% | -49.86% | -70.71% | -141.19% | -188.04% | - |
Revenue as Reported | 441.73 | 460.16 | 398.99 | 266.72 | 215.04 | 144.31 |